Compare RHI & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RHI | TXG |
|---|---|---|
| Founded | 1948 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | N/A | 2019 |
| Metric | RHI | TXG |
|---|---|---|
| Price | $27.26 | $20.49 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 6 | 14 |
| Target Price | ★ $36.00 | $16.18 |
| AVG Volume (30 Days) | 2.3M | ★ 2.6M |
| Earning Date | 01-29-2026 | 02-12-2026 |
| Dividend Yield | ★ 8.71% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.33 | N/A |
| Revenue | ★ $5,378,506,000.00 | $641,814,000.00 |
| Revenue This Year | N/A | $4.94 |
| Revenue Next Year | $0.76 | N/A |
| P/E Ratio | $20.39 | ★ N/A |
| Revenue Growth | N/A | ★ 1.92 |
| 52 Week Low | $25.22 | $6.78 |
| 52 Week High | $70.35 | $23.56 |
| Indicator | RHI | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 45.04 | 53.90 |
| Support Level | $26.76 | $19.34 |
| Resistance Level | $29.31 | $23.56 |
| Average True Range (ATR) | 1.08 | 1.35 |
| MACD | -0.14 | -0.12 |
| Stochastic Oscillator | 23.88 | 42.29 |
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).